GLP1R antagonist (IURTC)

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameGLP1R antagonist (IURTC)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsHypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University Research and Technology Corporation
China Registration ClassN/A

Develop Information

Active CompaniesIndiana University Research and Technology Corporation
Inactive CompaniesN/A
Active IndicationsHypoglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A